Kishore R Alugupalli

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Inflammatory Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kishore R Alugupalli
Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines. ImmunoHorizons 8 (4) (2024)
Kishore R Alugupalli
TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity. ImmunoHorizons 8 (1) (2024)
Kishore R Alugupalli
Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines. ImmunoHorizons 8 (4) (2024)
Kishore R Alugupalli
Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines. ImmunoHorizons 8 (4) (2024)
Kishore R Alugupalli
TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity. ImmunoHorizons 8 (1) (2024)
Kishore R Alugupalli
TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity. ImmunoHorizons 8 (1) (2024)
Kishore R Alugupalli
Characterization of Turbo, a TLR Ligand-based Adjuvant for Glycoconjugate Vaccines. ImmunoHorizons 8 (8) (2024)
Kishore R Alugupalli
TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity. ImmunoHorizons 8 (1) (2024)